Back to search results

Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline

Abroad (travel likely)RecruitingPHASE2

Conditions

Tuberculosis, Pulmonary

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Makerere University Lung Institute, Kampala, Kampala, Uganda

    Contact: Study coordinator (Ahmed Ddungu, MBCHB,MMED) · ahddungu@yahoo.com · +256782303377
    Contact: Study coordinator (Bruce Kirenga, MBCHB,PHD) · brucekirenga@yahoo.co.uk · 256782404431
    Contact: Principal Investigator (Ahmed Ddungu, MBCHB,MMED)
    Bruce Kirenga, MBCHB,PHD (Sub-investigator)
    Harriet Mayanja, MBCHB,PHD (Sub-investigator)
    Lucian Davis, MD (Sub-investigator)

  • Mulago National Referral Hospital, Kampala, Uganda

    Contact: Study coordinator (Ahmed Ddungu, MBCHB, M.MED-Internal Medicine) · ahddungu@yahoo.com · +256782303377
View source on ClinicalTrials.gov(opens in a new tab)